+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tretten Or Novothirteen Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • PDF Icon

    Report

  • 175 Pages
  • April 2025
  • Region: Global
  • The Business Research Company
  • ID: 6103989
The tretten or novothirteen market research report is one of a series of new reports that provides tretten or novothirteen market statistics, including the tretten or novothirteen industry global market size, regional shares, competitors with the tretten or novothirteen market share, detailed tretten or novothirteen market segments, market trends, and opportunities, and any further data you may need to thrive in the tretten or novothirteen industry. This tretten or novothirteen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The growth in the forecast period can be attributed to shift towards prophylactic treatment regimens, development of extended half-life therapies, shift from plasma-derived therapies, focus on personalized medicine, and expansion of healthcare access. Major trends in the forecast period include advancements in recombinant technology, advancements in drug development, advancements in biotechnology, technological advancements in clotting factor replacement, and advancements in clinical research.

The increasing awareness of rare bleeding disorders is expected to boost the growth of the tretten or novothirteen market. Rare bleeding disorders, such as hemophilia, von Willebrand disease, and factor XIII deficiency, are conditions that hinder the blood’s ability to clot properly. The growing awareness of these disorders is driven by advancements in diagnostic technologies, patient advocacy, and educational campaigns, which contribute to earlier detection, improved treatment access, and better patient outcomes. Tretten (NovoThirteen) is used in treating rare bleeding disorders by providing a recombinant form of activated Factor XIII, which is crucial for stabilizing blood clots and reducing the risk of bleeding in patients with Factor XIII deficiency. For example, according to the National Institute for Health and Care Excellence, in 2022-2023, 2,069 people in the UK were diagnosed with hemophilia B, including 374 with severe cases and 351 with moderate cases. This increased awareness is contributing to the growth of the tretten or novothirteen market.

The rise in healthcare expenditure is also expected to drive the growth of the tretten or novothirteen market. Healthcare expenditure represents the total financial resources allocated to healthcare services by governments, businesses, and individuals, including medical treatments, hospital care, medications, and public health initiatives. The increase in spending is due to factors such as advancements in medical technology, a growing demand for healthcare services, and a heightened focus on quality patient care, which has led to more global investments. With increased healthcare expenditure, more funds are directed toward research, development, and the accessibility of treatments for rare and complex conditions such as congenital Factor XIII deficiency, which tretten is designed to treat. For instance, the Centers for Medicare and Medicaid Services reported that US healthcare spending rose by 4.1% in 2022, reaching a total of $4.5 trillion, surpassing the 3.2% increase from 2021. This growing expenditure is fueling the growth of the tretten or novothirteen market.

The rising demand for personalized medicine is another factor expected to propel the growth of the tretten or novothirteen market. Personalized medicine is a healthcare approach that tailors treatment plans to individual patients based on their genetic makeup, lifestyle, and environmental factors, aiming to enhance the effectiveness of care. The growing demand for personalized medicine is driven by advancements in genomics and diagnostic technologies, which enable more individualized and effective treatments. Tretten (NovoThirteen) serves as a form of personalized medicine by offering targeted treatment for patients with hemophilia B, addressing their specific clotting factor deficiencies and improving bleeding control while reducing the risk of bleeding episodes. For example, the Personalized Medicine Coalition reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, a significant increase from the six approvals in 2022. Among these new treatments, seven were cancer drugs, and three targeted other conditions. The rising demand for personalized medicine is thus contributing to the growth of the tretten or novothirteen market.

The key company operating in the tretten or novothirteen market is Novo Nordisk A/S.

North America was the largest region in the tretten or novothirteen market in 2024. The regions covered in tretten or novothirteen report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tretten or novothirteen market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

Tretten (Novothirteen) is a recombinant therapy designed to treat factor XIII deficiency, a rare bleeding disorder. It works by providing recombinant factor XIII, which helps stabilize blood clots by cross-linking fibrin strands. Typically administered through intravenous infusion, Tretten is also used in the treatment of conditions such as paroxysmal nocturnal hemoglobinuria (PNH) or atypical hemolytic uremic syndrome (aHUS) to reduce the risk of complications, such as organ damage or blood clot formation.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main indications for Tretten (Novothirteen) include hemophilia B and surgical prophylaxis. Hemophilia B is a genetic disorder caused by a deficiency of clotting factor IX, leading to impaired blood clotting and excessive bleeding. Tretten is available in various formulations, including lyophilized powder and intravenous solution. It is distributed through multiple channels, including hospitals, clinics, retail and specialty pharmacies, and is used by a range of patients, including both adults and children.

The tretten or novothirteen market consists of sales of plasma-derived factor XIII concentrates, diagnostic kits, assays, and ancillary products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Tretten Or Novothirteen Market Characteristics
3. Tretten Or Novothirteen Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Tretten Or Novothirteen Market Trends And Strategies5. Tretten Or Novothirteen Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
6. Global Tretten Or Novothirteen Growth Analysis And Strategic Analysis Framework
6.1. Global Tretten Or Novothirteen PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Tretten Or Novothirteen Market Growth Rate Analysis
6.4. Global Tretten Or Novothirteen Historic Market Size and Growth, 2019 - 2024, Value ($ Million)
6.5. Global Tretten Or Novothirteen Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)
6.6. Global Tretten Or Novothirteen Total Addressable Market (TAM)
7. Global Tretten Or Novothirteen Pricing Analysis & Forecasts
8. Tretten Or Novothirteen Market Segmentation
8.1. Global Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Hemophilia B
  • Surgical Prophylaxis
8.2. Global Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Lyophilized Powder
  • Intravenous Solution
8.3. Global Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Hospital And Clinics
  • Retail And Specialty Pharmacies
8.4. Global Tretten Or Novothirteen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Adult Patient
  • Pediatric Patients
9. Global Tretten Or Novothirteen Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Tretten Or Novothirteen Market Regional And Country Analysis
10.1. Global Tretten Or Novothirteen Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
10.2. Global Tretten Or Novothirteen Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11. Asia-Pacific Tretten Or Novothirteen Market
11.1. Asia-Pacific Tretten Or Novothirteen Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.3. Asia-Pacific Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.4. Asia-Pacific Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
12. China Tretten Or Novothirteen Market
12.1. China Tretten Or Novothirteen Market Overview
12.2. China Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.3. China Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.4. China Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
13. India Tretten Or Novothirteen Market
13.1. India Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.2. India Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.3. India Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14. Japan Tretten Or Novothirteen Market
14.1. Japan Tretten Or Novothirteen Market Overview
14.2. Japan Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.3. Japan Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.4. Japan Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15. Australia Tretten Or Novothirteen Market
15.1. Australia Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.2. Australia Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.3. Australia Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16. South Korea Tretten Or Novothirteen Market
16.1. South Korea Tretten Or Novothirteen Market Overview
16.2. South Korea Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.3. South Korea Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.4. South Korea Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17. Western Europe Tretten Or Novothirteen Market
17.1. Western Europe Tretten Or Novothirteen Market Overview
17.2. Western Europe Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.3. Western Europe Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.4. Western Europe Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18. UK Tretten Or Novothirteen Market
18.1. UK Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.2. UK Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.3. UK Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19. Germany Tretten Or Novothirteen Market
19.1. Germany Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.2. Germany Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.3. Germany Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20. France Tretten Or Novothirteen Market
20.1. France Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.2. France Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.3. France Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21. Eastern Europe Tretten Or Novothirteen Market
21.1. Eastern Europe Tretten Or Novothirteen Market Overview
21.2. Eastern Europe Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.3. Eastern Europe Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.4. Eastern Europe Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22. North America Tretten Or Novothirteen Market
22.1. North America Tretten Or Novothirteen Market Overview
22.2. North America Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.3. North America Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.4. North America Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23. USA Tretten Or Novothirteen Market
23.1. USA Tretten Or Novothirteen Market Overview
23.2. USA Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.3. USA Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.4. USA Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24. Canada Tretten Or Novothirteen Market
24.1. Canada Tretten Or Novothirteen Market Overview
24.2. Canada Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.3. Canada Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.4. Canada Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25. South America Tretten Or Novothirteen Market
25.1. South America Tretten Or Novothirteen Market Overview
25.2. South America Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.3. South America Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.4. South America Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26. Middle East Tretten Or Novothirteen Market
26.1. Middle East Tretten Or Novothirteen Market Overview
26.2. Middle East Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.3. Middle East Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.4. Middle East Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27. Africa Tretten Or Novothirteen Market
27.1. Africa Tretten Or Novothirteen Market Overview
27.2. Africa Tretten Or Novothirteen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.3. Africa Tretten Or Novothirteen Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.4. Africa Tretten Or Novothirteen Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
28. Tretten Or Novothirteen Market Competitive Landscape And Company Profiles
28.1. Tretten Or Novothirteen Market Competitive Landscape
28.2. Tretten Or Novothirteen Market Company Profiles
28.2.1. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
29. Global Tretten Or Novothirteen Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Tretten Or Novothirteen Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Tretten Or Novothirteen Market32. Recent Developments In The Tretten Or Novothirteen Market
33. Tretten Or Novothirteen Market High Potential Countries, Segments and Strategies
33.1 Tretten Or Novothirteen Market In 2029 - Countries Offering Most New Opportunities
33.2 Tretten Or Novothirteen Market In 2029 - Segments Offering Most New Opportunities
33.3 Tretten Or Novothirteen Market In 2029 - Growth Strategies
33.3.1 Market Trend Based Strategies
33.3.2 Competitor Strategies
34. Appendix
34.1. Abbreviations
34.2. Currencies
34.3. Historic And Forecast Inflation Rates
34.4. Research Inquiries
34.5. About the Analyst
34.6. Copyright And Disclaimer

Executive Summary

Tretten Or Novothirteen Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tretten or novothirteen market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for tretten or novothirteen ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tretten or novothirteen market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Clinical Indication: Hemophilia B; Surgical Prophylaxis
2) By Formulation: Lyophilized Powder; Intravenous Solution
3) By Distribution Channel: Hospital And Clinics; Retail And Specialty Pharmacies
4) By End User: Adult Patient; Pediatric Patients

Key Companies Profiled: Novo Nordisk A/S

Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • Novo Nordisk A/S